Chimeras - no longer a myth
Since its first successful application less than 15 years ago, allogeneic marrow transplantation has been used with continuously improving results for the treatment of severe aplastic anemia, leukemia and congenital immunodeficiency syndromes. With this background, a recent meeting* * A UCN-UCLA Symposium on recent advances in bone-marrow transplantation was held in Park City, Utah, on 13-18 February 1983. provided an excellent opportunity to critically review problems and achievements of marrow transplant and non-transplant approaches to the treatment of malignant and nonmalignant lymphohemopoietic disorders. © 1983.
Volume / Issue
Start / End Page
International Standard Serial Number (ISSN)
Digital Object Identifier (DOI)